Prometheus is a modern hybrid-indica variety resulting from a complex cross between 303 OG, Purple Tahoe Alien, Tahoe OG, and Yeti OG. The lineage reflects a deliberate focus on OG-dominant genetics, though the specific origins and individual breeders associated with the development of this hybrid remain undocumented. Designed for cultivators of moderate experience, this strain performs well in both indoor and outdoor environments, reaches maturity in 60 days of flowering, and is recognized for producing a high yield.

The chemical composition of Prometheus is defined by a confirmed terpene profile that runs from myrcene as the primary, followed by limonene, caryophyllene, linalool, humulene, beta-pinene, and finally pinene. Based on these concentrations, users can expect an aromatic experience shaped by this specific sequence of compounds. While exact potency fluctuates by batch, the strain possesses an estimated THC content of approximately 16.6%, with negligible levels of CBD.

As a contemporary hybrid-indica, Prometheus is noted for providing effects that are simultaneously relaxed and focused. These characteristics make it a functional choice for addressing physical pain, chronic stress, or difficulties with sleep. While the strain remains a staple for its specific balanced profile, there are currently no recorded notable offspring descending from this particular genetic line.